Bipolar disorder and difficulties in treatment adherence
PDF (Portuguese (Brazil))

Keywords

Bipolar disorder
Treatment adherence
Psychiatry

How to Cite

Bipolar disorder and difficulties in treatment adherence. (2026). Electronic Journal Collection Health, 26(11), e25339. https://doi.org/10.25248/reas.e25339.2026

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: To understand the difficulties of adherence to treatment for Bipolar Disorder through literature review, in order to assist new studies on the subject. Methods: Integrative review in the PubMed database using the descriptors: bipolar disorder AND adherence, followed by previously determined filters and criteria. Two categories were established for analysis: Non-adherence to Treatment and Consequences of Suboptimal Adherence, aiming to structure the discussion of the articles. Results: A total of 24 articles were selected, with 17 articles in the first category and 7 in the second, which highlight the difficulties and consequences of non-adherence to treatment, including an increased risk of recurrence, relapse, hospitalization, and worsening prognosis. Metabolic outcomes and psychiatric comorbidities were identified as important factors contributing to treatment ineffectiveness, potentially leading to early morbidity. Final considerations: Non-adherence to TB  treatment increases the risk of relapse, worsening of symptoms, and negative impacts on quality of life, in addition to imposing a financial burden on the healthcare system. Therefore, strengthening early identification and strategies to improve treatment adherence is essential for healthcare professionals.

PDF (Portuguese (Brazil))

References

AWASTHI S, et al. The effect of early initiation of aripiprazole once-monthly 400 mg on health care resource utilization and health care costs in patients diagnosed with bipolar I disorder: Real-world evidence from US claims data. Journal of Managed Care & Specialty Pharmacy, 2026; 32(1): 66-74.

BRASIL. Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas: Transtorno Afetivo Bipolar do tipo I. Brasília: Ministério da Saúde, 2016.

BRASIL. Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde. Departamento de Assistência Farmacêutica e Insumos Estratégicos Relação Nacional de Medicamentos Essenciais: Rename 2024, Brasília: Ministério da Saúde, 2024.

CARVALHO DR, et al. Abordagem integrada no tratamento do transtorno bipolar. Brazilian Journal of Implantology and Health Sciences, 2025; 7(1): 2048-2058.

DE LAS CUEVAS C, et al. Poor adherence to oral psychiatric medication in adults with bipolar disorder: The psychiatrist may have more influence than in other severe mental illnesses. Neuropsychopharmacologia Hungarica, 2021; 23(4): 347-362.

DIABY V, et al. Budget impact of aripiprazole once every 2 months long-acting injectable for adult patients with bipolar I disorder in the United States. Journal of Managed Care & Specialty Pharmacy, 2025; 31(1): 60-68.

DOME P, et al. Risco de suicídio no transtorno bipolar: uma breve revisão. Medicina (Kaunas), 2019; 55(8):403.

FAUGÈRE M, et al. Clinical profiles, treatment adherence, and quality of life in patients with severe mental disorders treated with cyamemazine: A real-world observational study. L’Encéphale, 2025; 51(6): 635-642.

FISCHER R, et al. Treatment Preferences in Acute Psychosis: A Comparison of Patient and Staff Perspectives on Symptom Prioritization and Biopsychosocial Interventions. Psychiatric Quarterly, 2025; 96(1): 1-16.

GLITLIN MJ, MIKLOWITZ DJ. The difficult lives of individuals with bipolar disorder: A review of functional outcomes and their implications for treatment. Journal of Affective Disorders, 2017; 209: 147-154.

JAIN A, MITRA P. Bipolar Disorder. StatPearls, 2023.

KHALIF TC, et al. Terapia de aceitação e compromisso para o transtorno do humor bipolar: um estudo de revisão. Revista Perspectivas, 2025; 16 (2): 458-469.

KHANDKER R, et al. Prevalence and impact of antipsychotic discontinuation among commerc ially insured patients with bipolar disorder. Journal of Medical Economics, 2023; 26(1): 878-885.

LEVIN JB, et al. A 6-month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar-specific educational control in poorly adherent adolescents and young adults living with bipolar disorder. Bipolar Disorders, 2024; 26(7): 696-707.

LINTUNEN J, et al. Non-adherence to mood stabilizers and antipsychotics among persons with bipolar disorder – A nationwide cohort study. Journal of Affective Disorders, 2023; 333:403-408

MARZANI G, PRICE NEFF A. Bipolar disorders: Evaluation and treatment. American Family Physician, 2021; 103(4): 227-239.

MCVOY M, et al. A customized adherence enhancement program for adolescents and young adults with suboptimal adherence and bipolar disorder: Trial design and methodological report. Contemporary Clinical Trials, 2022; 115: 106729.

MERIKANGAS KR, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Archives of General Psychiatry, 2011; 68(3): 241-251.

MIKLOWITZ DJ, et al. Adjunctive psychotherapy for Bipolar Disorder: A systematic review and component network meta-analysis.JAMA Psychiatry,2021; 78(2): 141–150.

NA JJ, et al. Reducing public stigma toward bipolar disorder: Interventions and outcomes. Journal of Affective Disorders, 2026; 392: 120083.

NIERENBERG AA, et al. Diagnosis and Treatment of Bipolar Disorder: A Review. JAMA, 2023; 330(14):1370-1380.

NIOT C, et al. Clinical pharmacy activities specific to patients treated with lithium. L’Encéphale, 2025; 51(6): 592-600.

OLIVEIRA AT, et al. Estratégias farmacológicas no Transtorno Bipolar de difícil tratamento. Journal of Medical and Biosciences Research, 2025; 2(5): 997 – 1005.

PEREIRA CS, et al. A grounded theory on acceptance of diagnosis as a pathway to recovery in bipolar disorder. Scientific Reports, 2024; 14(1): 13434.

PERKINS AJ, et al. Association of antipsychotic-related weight gain with treatment adherence and switching using electronic medical records data. Prim Care Companion CNS Disord, 2023; 25(2): 22m03310.

POOJARI PG, et al. Consumers’ and practitioners’ perspectives on the antipsychotic induced metabolic syndrome and challenges in metabolic monitoring to patient prescribed second generation antipsychotics in severe mental illness. Journal of Health Psychology, 2025; 30(14): 4513-4527.

PRAJAPATI AR, et al. A qualitative investigation of the modifiable determinants of medication adherence in bipolar disorder (BD): Views of patients and their family and friends. Journal of Affective Disorders, 2025; 382: 462-470.

RAHIMI CHAHOOEI M, et al. Executive function performance in high and low medication adherent patients with euthymic bipolar I disorder: A comparative study. BMC Psychiatry, 2025; 25(1): 239.

SAJATOVIC M, et al. Long-Acting Injectable Antipsychotic Medication Plus Customized Adherence Enhancement in Poor Adherence Patients with Bipolar Disorder. Prim Care Companion CNS Disord, 2021; 23(5): 20m02888.

SAJATOVIC M, et al. Association Between Adherence Barriers, Self-Reported Adherence, and Psychiatric Symptoms Among Adults with Bipolar Disorder. Bipolar Disorders, 2025; 27(8): 567-577.

SAJATOVIC M, et al. Association Between Symptom Severity and Medication Adherence in Adults with Bipolar Disorder Reporting Adherence Challenges. Psychopharmacology Bulletin, 2024; 54(3): 60-72.

SENNER F, et al. Medication adherence and cognitive performance in schizophrenia-spectrum and bipolar disorder: results from the PsyCourse Study. Translational Psychiatry, 2023; 13(1): 99.

TAMBUZZI S, et al. Mood disorders and suicide: pilot study on postmortem toxicologic evidence and adherence to psychiatric therapy by determining blood levels of medications. International Journal of Legal Medicine, 2025; 139(1): 319-334.

TAMENE FB, et al. Medication non-adherence and its predictors among patients with bipolar disorder in Northwest Ethiopia. Scientific Reports, 2025; 15(1): 1192.

TAVEIRA CO, et al. Psicoeducação no transtorno bipolar: uma revisão sistemática Archives of Health, 2024; 5 (3): 01-08.

VU TS, et al. Factors associated with treatment non-adherence among patients with bipolar disorder in Vietnam. East Asian Archives of Psychiatry, 2025; 35(1): 32-36.

ZAFRA VB, et al. Transtorno bipolar e o dilema na adesão ao tratamento medicamentoso: Revisão de literatura. COORTE - Revista Científica Do Hospital Santa Rosa, 2024; 17(17).

ZHONG Y, et al. Global, regional and national burdens of bipolar disorders in adolescents and young adults: A trend analysis from 1990 to 2019. General Psychiatry, 2024; 37(1): e101255.